Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.

Adolescent Adult Aged Cell-Free Nucleic Acids / genetics Early Detection of Cancer / methods Erdheim-Chester Disease / blood Female Genomics / methods High-Throughput Nucleotide Sequencing Histiocytosis, Sinus / blood Humans Leukemia, Myeloid / diagnosis Male Middle Aged Mitogen-Activated Protein Kinases / genetics Mutation Polymerase Chain Reaction Proto-Oncogene Proteins B-raf / genetics Young Adult

Journal

Molecular cancer therapeutics
ISSN: 1538-8514
Titre abrégé: Mol Cancer Ther
Pays: United States
ID NLM: 101132535

Informations de publication

Date de publication:
06 2019
Historique:
received: 30 10 2018
revised: 16 12 2018
accepted: 05 04 2019
pubmed: 25 4 2019
medline: 9 4 2020
entrez: 25 4 2019
Statut: ppublish

Résumé

The

Identifiants

DOI: 10.1158/1535-7163.MCT-18-1244 PMID: 31015311 PMC: PMC6548628
pubmed: 31015311
pii: 1535-7163.MCT-18-1244
doi: 10.1158/1535-7163.MCT-18-1244
pmc: PMC6548628
mid: NIHMS1526992
doi:

Substances chimiques

Cell-Free Nucleic Acids 0
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1
Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1149-1157

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA023100
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA201247
Pays : United States

Informations de copyright

©2019 American Association for Cancer Research.

Références

Oncotarget. 2015 May 20;6(14):12809-21
pubmed: 25980577
Blood. 2014 Nov 6;124(19):3016-9
pubmed: 25150293
Cancer Res. 2014 Dec 15;74(24):7181-4
pubmed: 25326492
J Clin Oncol. 2010 Nov 1;28(31):e633-6
pubmed: 20733125
Blood. 2014 Aug 14;124(7):1062-9
pubmed: 24986690
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Int J Cancer. 2016 Feb 15;138(4):881-90
pubmed: 26314551
Clin Cancer Res. 2012 Jun 15;18(12):3462-9
pubmed: 22421194
Oncologist. 2013;18(1):2-4
pubmed: 23299771
Orphanet J Rare Dis. 2013 Sep 08;8:137
pubmed: 24011030
Arch Pathol. 1969 Jan;87(1):63-70
pubmed: 5782438
J Natl Cancer Inst. 2015 Nov 12;108(1):
pubmed: 26563355
Nat Genet. 2011 Dec 11;44(1):53-7
pubmed: 22158538
Mayo Clin Proc. 2014 Jul;89(7):985-96
pubmed: 24814521
Nat Biotechnol. 2013 Nov;31(11):1023-31
pubmed: 24142049
Cancer Discov. 2015 Jan;5(1):64-71
pubmed: 25324352
Clin Cancer Res. 2018 Aug 1;24(15):3539-3549
pubmed: 29691297
Haematologica. 2018 Apr;103(4):e177-e180
pubmed: 29472347
Oncotarget. 2014 Jun 15;5(11):3607-10
pubmed: 25003820
Medicine (Baltimore). 1996 May;75(3):157-69
pubmed: 8965684
Hum Pathol. 2011 Aug;42(8):1078-88
pubmed: 21334718
PLoS One. 2015 Oct 16;10(10):e0140712
pubmed: 26474073
Trends Mol Med. 2006 Sep;12(9):406-14
pubmed: 16899407
Cancer Discov. 2016 Feb;6(2):154-65
pubmed: 26566875
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
JAMA Oncol. 2017 Sep 1;3(9):1253-1256
pubmed: 28253394
Cancer Cell. 2004 Oct;6(4):313-9
pubmed: 15488754
Blood. 2016 Oct 6;128(14):1896-1898
pubmed: 27535996
Hum Mol Genet. 2016 Apr 1;25(7):1255-70
pubmed: 26758871
Mol Cancer Ther. 2016 Jun;15(6):1397-404
pubmed: 27207774
Genes Chromosomes Cancer. 2013 Nov;52(11):1075-87
pubmed: 23999936
Cancer Discov. 2018 Feb;8(2):184-195
pubmed: 29247021
N Engl J Med. 2017 Dec 14;377(24):2398-2399
pubmed: 29236635
JCO Precis Oncol. 2017 Jun;1:
pubmed: 28681041
Cancer Cell. 2012 Aug 14;22(2):180-93
pubmed: 22897849
Exp Mol Pathol. 2013 Dec;95(3):336-42
pubmed: 24161954
JAMA Oncol. 2018 Mar 1;4(3):384-388
pubmed: 29188284
Blood. 2012 Sep 27;120(13):2700-3
pubmed: 22879539
Br J Haematol. 2018 Jan;180(1):150-153
pubmed: 27711968
Blood. 2017 Aug 24;130(8):1007-1013
pubmed: 28679734
Anticancer Res. 2017 Jun;37(6):2777-2783
pubmed: 28551613
Blood. 2005 Nov 1;106(9):2992-4
pubmed: 16020507
Blood. 2016 Jun 2;127(22):2672-81
pubmed: 26966089
Lancet Oncol. 2017 Feb;18(2):e113-e125
pubmed: 28214412
PLoS One. 2011;6(7):e22769
pubmed: 21829508
JAMA Oncol. 2019 Feb 1;5(2):173-180
pubmed: 30325992

Auteurs

Filip Janku (F)

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org diamone1@mskcc.org.

Eli L Diamond (EL)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York. fjanku@mdanderson.org diamone1@mskcc.org.

Aaron M Goodman (AM)

Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California.

Vaijayanthi Kandadai Raghavan (VK)

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

Tamara G Barnes (TG)

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

Shumei Kato (S)

Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California.

Omar Abdel-Wahab (O)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Benjamin H Durham (BH)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

Funda Meric-Bernstam (F)

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

Razelle Kurzrock (R)

Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › Acides nucléiques acellulaires › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Diagnostic › Diagnostic précoce › Dépistage précoce du cancer › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Maladies lymphatiques › Histiocytose › Histiocytose non langerhansienne › Maladie d'Erdheim-Chester › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Maladies lymphatiques › Histiocytose › Histiocytose non langerhansienne › Histiocytose sinusale cytophagique › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Leucémies › Leucémie myéloïde › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Protein-Serine-Threonine Kinases › Mitogen-Activated Protein Kinases › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Techniques d'amplification d'acides nucléiques › Réaction de polymérisation en chaîne › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Kinases raf › Protéines proto-oncogènes B-raf › Molecular Profiling of Tumor Tissue and Plasma...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Molecular Profiling of Tumor Tissue and Plasma...